Robert Plenge
Net worth: 2 M $ as of 2026-08-30
Net worth: 2 M $ as of 2026-08-30
Dr. Robert M.
Plenge is an Independent Director at BioMarin Pharmaceutical, Inc. and a Chief Research Officer, EVP & Head-Research at Bristol Myers Squibb Co. He is on the Board of Directors at BioMarin Pharmaceutical, Inc. and PhRMA Foundation.
Dr. Plenge was previously employed as a VP-Translational Development & Research by Celgene Corp., a Vice President & Head-Translational Medicine by Merck & Co., Inc., an Associate Member-Broad Institute by The Brigham & Women's Hospital, Inc., and an Associate Member by The Broad Institute, Inc. He also served on the board at Translate Bio, Inc. He received his undergraduate degree from the University of California San Diego and a doctorate degree from Case Western Reserve University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-09 | 24,754 ( 0% ) | 2 M $ | 2026-08-30 | |
| 2026-09-09 | 6,140 ( 0% ) | 400 512 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 2019-10-31 |
| BIOMARIN PHARMACEUTICAL INC. | Director/Board Member | 2026-09-09 |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Director/Board Member | - |
Alltrna
Alltrna Pharmaceuticals: MajorHealth Technology Develops tRNA-based medicines for genetic disorders | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| TRANSLATE BIO, INC. | Director/Board Member | 2021-09-13 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2017-04-30 |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | 2012-12-31 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Corporate Officer/Principal | 2012-12-31 |
| CELGENE | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Translate Bio, Inc.
Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Alltrna
Alltrna Pharmaceuticals: MajorHealth Technology Develops tRNA-based medicines for genetic disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions